Japan will supply medicine against coronavirus to 43 countries for free

US, WASHINGTON (ORDO NEWS) — Japan will start free delivery of Avigan, also known as Favipiravir and Failover, to 43 countries as a promising treatment for pneumonia caused by a new type of coronavirus, Foreign Minister Toshimitsu said at a press conference in Tokyo Motegi.

“During telephone conversations with the foreign ministers of each country, it turned out that there was great interest in Avigan. We received requests for the delivery of Avigan from almost 80 countries through diplomatic channels. To date, we have agreed on delivery details with 43 countries. But we’ll be able to start delivery shortly after the weekend. As for the quantity, since we are talking about clinical trials, an amount sufficient to treat 20 people will be sent to each country, a maximum of 100,” the minister said.

The medicine was developed to treat the flu six years ago. However, then, during experiments on animals, side effects were discovered during fetal development. As a result, he was excluded from use by pregnant women and was included in the list of drugs for which treatment is possible by special order of the government if all other drugs do not work.

Meanwhile, Chinese doctors have discovered its effectiveness in treating pneumonia caused by a new type of coronavirus infection.

In March, Japan began conducting clinical trials on 80 patients infected with a new type of coronavirus, with mild symptoms and no symptoms. Now in Japan there is a supply of Avigan, sufficient to treat two million people.

According to the latest data, the number of detected cases of COVID-19 in Japan amounted to 15,278 people, including 712 infected on the Diamond Princess cruise ship, which was quarantined off the coast of Japan in February. On Friday, 261 new infections were detected. 490 people died from coronavirus in Japan. The condition of 332 people is assessed as serious. 4632 people recovered.

Online:

Contact us: [email protected]

Our Standards, Terms of Use: Standard Terms And Conditions.